48 related articles for article (PubMed ID: 27797320)
1. CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruption.
Siberry GK; Patel K; Van Dyke RB; Hazra R; Burchett SK; Spector SA; Paul ME; Read JS; Wiznia A; Seage GR;
J Acquir Immune Defic Syndr; 2011 Jul; 57(3):223-9. PubMed ID: 21423022
[TBL] [Abstract][Full Text] [Related]
2. Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection.
Childers ME; Woods SP; Letendre S; McCutchan JA; Rosario D; Grant I; Mindt MR; Ellis RJ;
J Neurovirol; 2008 Nov; 14(6):550-7. PubMed ID: 19016380
[TBL] [Abstract][Full Text] [Related]
3. Paediatric antiretroviral update.
Sorour G; Sipambo N; Archary M
South Afr J HIV Med; 2023; 24(1):1506. PubMed ID: 38089886
[No Abstract] [Full Text] [Related]
4. Lamivudine monotherapy as a holding regimen for HIV-positive children.
Patten G; Bernheimer J; Fairlie L; Rabie H; Sawry S; Technau K; Eley B; Davies MA;
PLoS One; 2018; 13(10):e0205455. PubMed ID: 30308013
[TBL] [Abstract][Full Text] [Related]
5. Immunological failure in HIV-infected adults from 2003 to 2015 in Southwest Ethiopia: a retrospective cohort study.
Gesesew HA; Ward P; Woldemichael K; Mwanri L
BMJ Open; 2018 Aug; 8(8):e017413. PubMed ID: 30121586
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral therapy interruptions: impact on HIV treatment and transmission.
Dubrocq G; Rakhmanina N
HIV AIDS (Auckl); 2018; 10():91-101. PubMed ID: 29942160
[TBL] [Abstract][Full Text] [Related]
8. Interruptions of antiretroviral therapy in children and adolescents with HIV infection in clinical practice: a retrospective cohort study in the USA.
Rakhmanina N; Lam KS; Hern J; Young HA; Walters A; Castel AD
J Int AIDS Soc; 2016; 19(1):20936. PubMed ID: 27797320
[TBL] [Abstract][Full Text] [Related]
9. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
AIDS; 1998 Oct; 12(14):F151-60. PubMed ID: 9792371
[TBL] [Abstract][Full Text] [Related]
10. Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice.
Lackey P; Mills A; Carpio F; Hsu R; DeJesus E; Pierone G; Henegar C; Fusco J; Fusco G; Wohlfeiler M
Clin Drug Investig; 2017 Jan; 37(1):51-60. PubMed ID: 27587070
[TBL] [Abstract][Full Text] [Related]
11. Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial.
Agwu AL; Warshaw MG; McFarland EJ; Siberry GK; Melvin AJ; Wiznia AA; Fairlie L; Boyd S; Harding P; Spiegel HML; Abrams EJ; Carey VJ;
PLoS One; 2017; 12(6):e0178075. PubMed ID: 28604824
[TBL] [Abstract][Full Text] [Related]
12. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
[TBL] [Abstract][Full Text] [Related]
13. Structured interruptions of highly active antiretroviral therapy in cycles of 4 weeks off/12 weeks on therapy in children having a chronically undetectable viral load cause progressively smaller viral rebounds.
Palacios GC; Sanchez LM; Briones E; Ramirez TJ; Castillo H; Rivera LG; Vazquez CA; Rodriguez-Padilla C; Holodniy M
Int J Infect Dis; 2010 Jan; 14(1):e34-40. PubMed ID: 19467895
[TBL] [Abstract][Full Text] [Related]
14. BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial.
Butler K; Inshaw J; Ford D; Bernays S; Scott K; Kenny J; Klein N; Turkova A; Harper L; Nastouli E; Paparini S; Choudhury R; Rhodes T; Babiker A; Gibb D
Health Technol Assess; 2016 Jun; 20(49):1-108. PubMed ID: 27377073
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
